UK MHRA Will Not Implement Stricter Review For Existing Male Valproate Patients

 
• By Eliza Slawther
  
Valproate has been linked with an increased risk of neurodevelopmental disorders in children fathered by men taking the drug (Shutterstock)

More from Drug Safety

More from Pink Sheet